Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Novocure Ltd Ord Sh (NVCR)

172.38   4.1 (2.44%) 01-20 23:22
Open: 169.76 Pre. Close: 168.28
High: 175 Low: 168.55
Volume: 512,189 Market Cap: 17,548M
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. The company markets Optune and NovoTTF-100L, a Tumor Treating Fields delivery system for use as a monotherapy treatment for adult patients with glioblastoma. It is also developing products that are in Phase 2 pilot and Phase 3 pivotal trials for brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer, and mesothelioma. The company markets its products in the European Union, Japan, and internationally. It has a clinical trial collaboration agreement with MSD to evaluate tumor treating fields together with KEYTRUDA, an anti-PD-1 therapy; and a strategic alliance with the NYU Grossman School of Medicine's Department of Radiation Oncology that provides a framework for preclinical and clinical development projects studying Tumor Treating Fields. NovoCure Limited was founded in 2000 and is based in Saint Helier, Jersey.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 175.215 - 175.865 175.865 - 176.388
Low: 166.819 - 167.626 167.626 - 168.275
Close: 171.156 - 172.415 172.415 - 173.426

Technical analysis

as of: 2021-01-20 4:50:30 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 213.43     One year: 249.29
Support: Support1: 165.08    Support2: 154.17
Resistance: Resistance1: 182.74    Resistance2: 213.43
Pivot: 169.44
Moving Average: MA(5): 172.82     MA(20): 169.72
MA(100): 130.89     MA(250): 94.70
MACD: MACD(12,26): 5.37     Signal(9): 6.42
Stochastic oscillator: %K(14,3): 52.87     %D(3): 62.00
RSI: RSI(14): 57.41
52-week: High: 182.74  Low: 53.40  Change(%): 88.0
Average Vol(K): 3-Month: 112453  10-Days: 67891

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
NVCR has closed below upper band by 37.6%. Bollinger Bands are 18.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 20 Jan 2021
Check this Co-Diagnostics, Inc. (NASDAQ:CODX) Analysis Before You Invest - Stocks Register

Mon, 18 Jan 2021
Investors Take Advantage of 7.73% Gain In Biodesix, Inc. (NASDAQ:BDSX) - Stocks Register

Sat, 16 Jan 2021
Surgery Partners, Inc. (NASDAQ:SGRY)’s Share Price Jumped 1.23%, What’s Next? Here Is A Hint: Don’t Be Too Excited - Stocks Register

Sat, 16 Jan 2021
Sotera Health Company (NASDAQ:SHC): Making Its Way Up the Stock Market - Stocks Register

Fri, 15 Jan 2021
OpGen, Inc. (NASDAQ:OPGN) Stock: Looks Like A Good Investment - Stocks Register

Thu, 14 Jan 2021
XpresSpa Group, Inc. (NASDAQ:XSPA) Stock: Looks Like A Good Investment - Stocks Register

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Health Care Equipment & Services
Shares Out. (M) 102
Shares Float (M) 86
% Held by Insiders 14.82
% Held by Institutions 82.91
Shares Short (K) 5,880
Shares Short P. Month (K) 5,140

Stock Financials

EPS 0.180
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 3.020
Profit Margin 4.26
Operating Margin 4.18
Return on Assets (ttm) 2.7
Return on Equity (ttm) 7.7
Qtrly Rev. Growth 44.1
Gross Profit (p.s.) 2.584
Sales Per Share 4.417
EBITDA (p.s.) 0.258
Qtrly Earnings Growth 381.00
Operating Cash Flow (M) 53
Levered Free Cash Flow (M) 33

Stock Valuations

PE Ratio 957.67
PEG Ratio
Price to Book value 57.08
Price to Sales 39.03
Price to Cash Flow 333.43

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.